These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9511052)

  • 1. In-vitro activity of combined ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium: influence of the medium on susceptibility test results.
    Tripodi MF; Locatelli A; Rambaldi A; Rosario P; Utili R
    J Antimicrob Chemother; 1998 Jan; 41(1):139-40. PubMed ID: 9511052
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of the level of ampicillin resistance and the inoculum size on the in-vitro bactericidal activity of the combination of ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium.
    Tripodi MF; Rambaldi A; Sarnataro G; Ragone E; Utili R
    J Antimicrob Chemother; 1999 Nov; 44(5):719-20. PubMed ID: 10552994
    [No Abstract]   [Full Text] [Related]  

  • 3. Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
    Tripodi MF; Utili R; Rambaldi A; Locatelli A; Rosario P; Florio A; Ruggiero G
    J Antimicrob Chemother; 1996 Apr; 37(4):727-36. PubMed ID: 8722538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of resistant Enterococcus faecium to unusual antibiotics.
    Eng RH; Ng K; Smith SM
    J Antimicrob Chemother; 1993 Apr; 31(4):609-10. PubMed ID: 8514657
    [No Abstract]   [Full Text] [Related]  

  • 5. In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
    Kak V; You I; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):297-9. PubMed ID: 10974585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.
    Kariyama R; Kumon H; Chow L; Zervos MJ; Takata T; Tabata M; Chow JW
    J Antimicrob Chemother; 1998 Dec; 42(6):836-8. PubMed ID: 10052913
    [No Abstract]   [Full Text] [Related]  

  • 7. Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium.
    Fraimow HS; Venuti E
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1563-6. PubMed ID: 1510455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations.
    Messick CR; Rodvold KA; Pendland SL
    J Antimicrob Chemother; 1999 Dec; 44(6):831-4. PubMed ID: 10590287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple combined agar-strip test for detection of enterococcal susceptibility to ampicillin, moderate- or high-level gentamicin resistance and potential additive activity of ampicillin plus gentamicin.
    Traub WH; Leonhard B
    Chemotherapy; 1993; 39(2):82-7. PubMed ID: 8458250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
    Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
    Sánchez Valenzuela A; Lavilla Lerma L; Benomar N; Gálvez A; Pérez Pulido R; Abriouel H
    Foodborne Pathog Dis; 2013 Feb; 10(2):143-9. PubMed ID: 23259502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple test of synergy between ampicillin and vancomycin for resistant strains of Enterococcus faecium.
    Green M; Barbadora K; Wadowsky RM
    J Clin Microbiol; 1994 Nov; 32(11):2837-9. PubMed ID: 7852581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of quinupristin/dalfopristin and other antibiotics against ampicillin-resistant enterococcus faecium.
    Wang FD; Liu IM; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):119-23. PubMed ID: 10677922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterococcus faecium with high-level resistance to gentamicin and ampicillin: an emerging clinical problem.
    Seetulsingh P; Holliman RE
    J Antimicrob Chemother; 1994 Nov; 34(5):846-7. PubMed ID: 7706187
    [No Abstract]   [Full Text] [Related]  

  • 15. In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
    Dembry LM; Farrel PA; Orcutt DR; Gerrity LA; Andriole VT
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():35-42. PubMed ID: 9222068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-kill profiles of Enterococcus to antibiotics used for intravitreal therapy.
    Kowalski RP; Karenchak LM; Warren BB; Eller AW
    Ophthalmic Surg Lasers; 1998 Apr; 29(4):295-9. PubMed ID: 9571661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multicenter trial of Enterococcus antibiotic susceptibility].
    Sidorenko SV; Rezvan SP; Grudinina SA; Krotova LA; Sterkhova GV
    Antibiot Khimioter; 1998; 43(9):9-18. PubMed ID: 9791681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental endocarditis due to multidrug resistant Enterococcus faecium with ciprofloxacin and novobiocin.
    Quale JM; Landman D; Mobarakai N
    J Antimicrob Chemother; 1994 Nov; 34(5):797-802. PubMed ID: 7706176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.